The Test-to-PrEP Study
Part of paid clinical trials in Miami, Florida.
- Sponsor
- University of Miami
- Study ID
- NCT06927856
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Test-to-PrEP — BEHAVIORALParticipants, called Egos, will come once to the clinic throughout the duration of the study, for up to 1 hour. During the visit, participants will receive up to 4 Test-to-PrEP Packs, which include an HIV self-test kit and HIV prevention education materials and a brief (approximately 15 minutes) training. The training includes instructions on how to initiate conversations related to HIV, HIV testing, and HIV prevention, as well as proper handling of the HIV self-test kit. Participants are asked to distribute the Test-to-PrEP Packs to Social Network Contacts (peers), called Alters.
- Access by Referral — BEHAVIORALParticipants, called Egos, will receive up to 4 Access by Referral Cards once. Participants will receive a brief (approximately 15 minutes) training. The training includes instructions on how to initiate conversations related to HIV, HIV testing, and HIV prevention, as well as proper handling of the HIV self-test kit. Participants are asked to distribute the Access by Referral Cards to Social Network Contacts (peers), also called Alters. The Referral Card can be used to order a Test-to-PrEP Pack, including the HIV self-test and HIV prevention education material, that will be mailed to an address of the Alter's choice.
Study Details
To compare the effectiveness of two social network strategies (direct distribution and referral-based distribution) in increasing HIV self-testing (HIVST) completion rates among social network contacts of current Pre-Exposure Prophylaxis (PrEP) clients.
Key Dates
- Start date
- Apr 10, 2025
- Status verified
- Apr 2026
- Primary completion
- Jul 1, 2028
- Completion
- Jul 1, 2028
Study Design
- Enrollment
- 320 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Test-to-PrEP groupParticipants in this group will receive the Test-to-PrEP intervention for up to 1 year
- Experimental: Access by Referral groupParticipants in this group will receive the Access by Referral intervention for up to 1 year
Primary Outcome Measure
Number of Alter participants per ego who use the HIV self-test kit [ Time Frame: Up to 6 months ]
Central Contacts
- Susanne Doblecki-Lewis, MD3052434037
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Miami | Miami | Florida | 33136 | Susanne Dobleck-Lewis, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Miami, FL
By condition
By specialty
By research site
Related Studies
- Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV PreventionRecruiting · Public Health Foundation Enterprises, Inc. · San Francisco, California
- A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult ParticipantsPHASE1 · Recruiting · ViiV Healthcare · Orlando, Florida
- Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in PediatricsPHASE1/PHASE2 · Recruiting · ViiV Healthcare · Long Beach, California
- Comprehensive HIV and Harm Prevention Via TelehealthRecruiting · University of Miami · Miami, Florida